Global Transcriptomics Market Size | US$ 10.97 Bn Growth by 2029 | Leading Key Players Analysis

by kalpesh on April 5, 2024

21 views

Global Transcriptomics Market Expected to Reach Nearly US$10.97 Billion by 2029 at a CAGR of 5.50%

The global transcriptomics market is expected to grow steadily at a CAGR of 5.50% over the forecast period, reaching nearly US$10.97 billion by 2029, according to a new report by Maximize Market Research. This growth is driven by several factors, including:

Increasing adoption of transcriptomics in diagnostics and disease profiling
Rising focus on personalized medicine
Growing government funding for genomics research
Technological advancements in transcriptomics techniques

Please provide the link you'd like me to access for the preview of the dynamic: https://www.maximizemarketresearch.com/request-sample/108481

Market Scope:

The report provides valuable insights into the transcriptomics market, including its size, segmentation, growth drivers, and challenges. It also analyzes the competitive landscape and identifies key players in the market. This information can be used by companies to develop effective growth strategies and make informed investment decisions.

Segmentation:

The transcriptomics market is segmented by technology, application, and region. By technology, the market is segmented into microarray, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies. By application, the market is segmented into diagnostics and disease profiling, drug discovery, and others. By region, the market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East and Africa.

Key Players:

The major players in the transcriptomics market include Becton, Dickinson and Company (BDX), GE Healthcare (GE), Roche Diagnostics (RHHBY), Agilent Technologies (A), Thermo Fisher Scientific Inc. (TMO), Illumina, Inc. (ILMN), F. Hoffmann-La Roche Ltd (ROG), Beckman Coulter, Inc. (BEC), Bio-Rad Laboratories, Inc. (BIO), Cepheid (CPHD), Takara Bio Inc. (TKRA), and QIAGEN N.V. (QGEN).

Regional Analysis:

North America is expected to remain the dominant region in the transcriptomics market throughout the forecast period. However, the Asia Pacific region is expected to witness the fastest growth due to factors such as increasing government support for genomics research and a growing pool of patients.

COVID-19 Impact Analysis:

The COVID-19 pandemic has had a significant impact on the transcriptomics market. The pandemic has led to increased research on infectious diseases, which has boosted the demand for transcriptomics technologies. However, the pandemic has also disrupted supply chains and limited research activities in some regions.

Key Questions Answered in the Report: